The blog post discusses how the NVIDIA BioNeMo framework, integrated with Amazon SageMaker, can accelerate drug discovery. It explains the challenges of drug R&D, highlighting the cost and time involved. By leveraging generative AI for drug discovery, the BioNeMo framework allows researchers to develop advanced AI solutions for analyzing biomolecular data, thus potentially reducing the time and cost associated with bringing new drugs to market. For more information, you can read the full blog post here.
Resources :